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This study has examined whether the calcium-sensing receptor (CaSR) plays a role in control of stan-
niocalcin-1 (STC-1), the dominant calcium regulatory hormone of fish, comparable with that demon-
strated for CaSR in the mediation of ionized calcium regulation of PTH secretion in mammals. In a
previous study, we have cloned flounder STC-1 from the corpuscles of Stannius (CS). Here, we report
the cloning and characterization of the CS CaSR, and the in vivo responses of this system to altered
salinity, EGTA inducedhypocalcemia, and calcimimetic administration.QuantitativePCRanalysis dem-
onstrated, for the first time, that the CS are major sites of CaSR expression in flounder. Immunoblot
analysis of CS proteinswith CaSR-specific antibodies revealed a broadbandof approximately 215–300
kDa under nonreducing conditions, and bands of approximately 215–300 kDa and approximately
120–150 kDa under reducing conditions. There were no differences in CS CaSR mRNA expression or
plasma STC-1 levels between seawater and freshwater (FW)-adapted fish, although CS STC-1 mRNA
expressionwas lower in FWanimals. Immunoblots showed that glycosylatedmonomeric forms of the
CaSRmigratedata lowermolecularmass inCSsamplesfromFWanimals.TheipadministrationofEGTA
rapidly induced hypocalcemia, and a concomitant lowering of plasma STC-1. Calcimimetic adminis-
tration (1 mg/kg R-568) rapidly increased plasma STC-1 levels, and reduced plasma concentrations of
calcium, phosphate, and magnesium when compared with S-568-treated controls. Together, these
findings support an evolutionary conserved role for the CaSR in the endocrine regulation of calcium
before the appearance of parathyroid glands in tetrapods. (Endocrinology 150: 3002–3010, 2009)
The concentration of calcium in extracellular fluid is preciselyregulated throughout vertebrates fromfish tomammals.The
ability to sense changes in plasma-ionized calcium ismediated by
the calcium-sensing receptor (CaSR), which is an integral com-
ponent in regulating PTH secretion from the parathyroid glands
of mammals (1). The CaSR has more recently been cloned and
localized in a large number of tissue types in fish (2–4), many of
which seem to have a functional relationship with the regulation
of calcium (4–6).However, in fish, in the absence of parathyroid
glands, there are currently no data describing a comparable role
for the CaSR in the major calcium hormone regulatory systems,
which in bony fish are dominated by stanniocalcin-1 (STC-1).
In contrast to mammals, in which calcium is obtained from
dietary sources, in fish calcium is readily available from the sur-
rounding aquatic environment. Accordingly, fish calcium regu-
lation is predominantlymediated by the hypocalcemic hormone,
STC-1. The corpuscles of Stannius (CS), which are teleost-spe-
cific endocrine glands associated with the kidneys, synthesize
and secrete STC-1. Early studies showed that removal of these
glands resulted in the rapid onset of hypercalcemia, clearly un-
derscoring their role in calcium regulation (7). Actions of STC-1
on calcium homeostasis include inhibition of gill calcium trans-
port (8–10), reduced intestinal calcium uptake (11), and stim-
ulation of phosphate reabsorption by renal proximal tubules
(12). A second STC, STC-2, has been identified recently in fish
(13), but current evidence suggests that it does not play a signif-
icant role in calcium regulation (14). Synthesis and secretion of
STC-1 by the CS have been shown to be sensitive to extracellular
ISSN Print 0013-7227 ISSN Online 1945-7170
Printed in U.S.A.
Copyright © 2009 by The Endocrine Society
doi: 10.1210/en.2008-1758 Received December 18, 2008. Accepted March 11, 2009.
First Published Online March 19, 2009
Abbreviations: CaSR, Calcium-sensing receptor; CNSS, caudal neurosecretory system; CS,
corpuscles of Stannius; CT, calcitonin; FW, freshwater; GAPDH, glyceraldehyde-3-phos-
phate dehydrogenase; PNGase F, Peptide: N-Glycosidase F; RACE, rapid amplification of
cDNA end; SH, sulfhydryl; STC-1, stanniocalcin-1; SW, seawater.
C A L C I U M - R E G U L A T I N G H O R M O N E S
3002 endo.endojournals.org Endocrinology, July 2009, 150(7):3002–3010
ionized calcium concentration both in vitro and in vivo (15–17),
and it is suggested that regulationof STC-1 secretion from theCS
in fish, similar to that for PTH and calcitonin (CT) secretion in
mammals (18–20), involves the CaSR (21), though evidence to
support this is lacking. Accordingly, the overall aim of the cur-
rent study was to clarify the role of the CaSR in fish calcium
regulation by first cloning the CaSR in CS and then investigating
its expression in response to calcium challenge. These investiga-
tions have been performed in the euryhaline flounder, which can
accommodate both calcium-rich seawater (SW) and relatively
calcium-poor freshwater (FW), and from which we have also
previously cloned STC-1 (22).
The function and expression of fishCaSRs have been assessed
in transiently transfected human embryonic kidney cells, in
which sensitivity to calcium, magnesium, and sodium ions has
been demonstrated (4, 23), similar to that reported for mamma-
lian CaSRs (24). Furthermore, previous investigations in fish
found STC-1 producing cells to be metabolically more active in
SWby comparisonwith FW-adapted fish (25), reflecting the 10-
to 100-fold higher calcium content of SW. Therefore, onewould
predict higher levels of STC-1 secretion in SW compared with
FW fish, with consequent modifications in calcium fluxes to se-
cure stability of plasma composition. Interestingly, high levels of
STC-1 mRNA expression have been observed in a second fish-
specific endocrine tissue, the caudal neurosecretory system
(CNSS) (26). Therefore, we also report here on the expression of
CaSR along with STC-1 in the CS together with this novel ex-
pressing tissue (CNSS) in long-term SW and FW-adapted fish.
The cloning of the flounder CaSR revealed significant struc-
tural similarities with mammalian CaSRs, in particular, with
respect to potential sites for calcimimetic interactions. Thus, it
appeared likely that calcimimeticswould also be effective in fish.
Indeed, recently, Radman et al. (21) showed that the calcimi-
metic R-467 significantly enhanced the secretion of STC-1 in the
rainbow trout, leading to a reduction in gill calcium transport.
To further investigate CaSR activity in fish, we administered the
calcimimetic R-568 or its enantiomer S-568. In mammals, ad-
ministration of R-568 significantly decreases the secretion of
PTH from the parathyroid in vitro and in vivo (20), and increases
CT release from the thyroid gland (18). If the CaSR is central to
fish calcium regulation, then one might expect calcimimetics to
enhance CS sensitivity to calcium, if they act as in mammals,
resulting in increased STC-1 secretion, with consequent effects
on ion fluxes, and, thus, plasma and urine composition. The
results of this studyprovide compelling evidence fora central role
of the CaSR in systemic calcium regulation in fish.
Materials and Methods
Animals
The flounder, Platichthys flesus, were collected from Morecambe
Bay (Cumbria, UK) and transported to the aquarium facilities at the
University of Manchester. Flounder were of mixed sex and ranged in
weight from 300–500 g. The flounder were maintained in SW (Nature-
land, Skegness, UK) or FW (tap water) tanks at 10–12 C under a 12-h
light, 12-h dark cycle for at least 2 wk before experimentation. All ex-
periments were performed in accordance with United Kingdom Home
Office Regulatory requirements and local ethics committee approval.
Cloning of CaSR cDNA
Total RNA was extracted from tissues using TRIZOL reagent in ac-
cordance with the manufacturer’s protocol (Invitrogen, Paisley, UK),
and RNA yield was quantified using a NanoDrop (ND-1000) spectro-
photometer (NanoDrop, Wilmington, DE). For cDNA synthesis, 1 g
totalRNAwas treatedwith deoxyribonuclease I (Invitrogen) and reverse
transcribed using Invitrogen SuperScript II reverse transcriptase with
random primers, as recommended by the manufacturer. The RT-PCRs
were performed using Bioline reagents (Bioline, London, UK). The
primer pairings of CaSR3F (5-ACAGGATTGGATGTGCCGTTT-3)-
CaSR3R (5-CGTTGGTCTTGAGGCTGATGG-3) and CaSR4F (5-
CACCAGGCCACMGCCATG-3)-CaSR4R (5-AAKGTTTCCTCCCA-
AAACTC-3)were used to clone smallN-terminal andC-terminal portions
of the flounder CaSR from CS cDNA. The PCR cycle conditions for
CaSR3F-CaSR3R were: 94 C for 3 min, followed by 35 cycles of 94 C for
1min,59Cfor1min,72Cfor2min, and finally72Cfor10min.ThePCRs
using CaSR4F-CaSR4R were performed, as described previously, except
with an annealing temperature of 55C. The intermediate segment between
these fragmentswas amplified using primersCaSR5F (5-CTATTGGCTT-
TGCTCTGAAGGC-3)-CaSR5R (5-CAAGGATGCACGAGATACA-
GAG-3) and a cycling profile, as described previously, with an annealing
temperature of 60 C.
Rapid amplification of cDNA ends (RACEs)
The 5 and 3 ends of the flounder CaSR were amplified using Clon-
tech’s SMARTRACE cDNAAmplificationKit (Clontech,Oxford, UK).
ThecDNAfor5and3RACEwere synthesized from1gCS totalRNA.
The 5 and 3 ends of the cDNA encoding the flounder CaSR were
amplified using the primersCaSR5Race (5-ATGCCACAGCAATGAC-
CCAGTTCCACTCG-3) and CaSR3Race (5-GGATTGGATGTGC-
CGTTTACGCCAACCTGCCTTT-3), respectively. A touchdown PCR
protocolwas used following themanufacturer’s guidelines. The PCRprod-
ucts were ligated into pGEM-T vector (Promega, Southampton, UK).
Sequence analysis
Sequencing reactions were performed using Applied Biosystems
(ABI, Warrington, UK) BigDye sequencing kit version 1.1. Amino acid
sequence comparisons were performed using DNAMAN (Lynnon Bio-
soft, Quebec, Canada). The signal peptide was predicted using SignalP
3.0, potential regions of glycosylation using NetNGlyc 1.0, potential
sites for the initiationof phosphorylationusingNetPhos 2.0, and7 trans-
membrane segments using TMpred (www.cbs.dtu.dk).
Tissue distribution of CaSR and STC-1 mRNA
Real-time quantitative PCR analysis
The tissue distribution of the CaSR and STC-1 mRNAs were analyzed
in 18 tissues collected from six SW flounder using quantitative PCR. All
primers andTaqManprobeswere designedusing PrimerExpress (ABI) and
synthesized by Eurogentec (Lie`ge, Belgium): CaSR_sense-2695F_(5-
CCATACTGGCATCCAGCTTTG-3); CaSR_antisense-2773R_(5-CG-
GGACGGTTTGAAAAGGA-3); CaSR_TaqMan_probe-2721T_(5-FAM-
CTGGCCTGCATCTTCTTCAACAAGGTCT-TAMRA-3); STC-1_sense-
542F_(5-AAGGTAAAACCTTTGTGAAGAAGAC-3); STC-1_antisense-
618R_(5-GAAGTGAGCTGGTACCTGC-3); STC-1_TaqMan_probe-
571T_(5-FAM-TTCAGTGCATCTCCCAGGGAATCTCCT-TAMRA-3);
Actin_sense-352F_(5-AAGATGACCCAGATCATGTTCGA-3); Actin_
antisense-454R_(5-GAGCCACCAATCCACACAGA-3); and Actin _
TaqMan_probe382T_(5-FAM-AACACCCCCGCCATGTACGTTGC-
TAMRA-3).
The optimization and validation of primers and probes were per-
formed using standardABI protocols. PCRswere performed in triplicate
as described by Lu et al. (27). For absolute quantification of CaSR and
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STC-1 transcript copies, numbers were quantified as a comparison of
sample CT values for each reaction compared with standard curves gen-
erated from linearized plasmid clones in accordance with ABI protocols.
For the relative quantification ofCaSRand STC-1 gene expression in SW
vs. FW fish, the 2Ct methodwas used. The internal control gene used
for these analyses was the housekeeping gene -actin, though compara-
ble results were also obtained with 18S.
Northern blot analysis
Ten micrograms of total RNA from SW flounder CS tissue were
electrophoresed on a 1% denaturing agarose formaldehyde gel for 12 h
at 25V.TheRNAsampleswere thenblotted and subsequently fixedonto
Hybond N nylon membranes (Amersham Biosciences, Buckingham-
shire, UK) as previously described (26). The original C-terminal CaSR
fragment and full-length flounder STC-1 (22)were used as cDNAprobes
for Northern blotting.
Protein extraction
Tissues were obtained from SW (CS and CNSS) and FW (CS) accli-
mated flounder andhomogenized in ice-cold buffer as describedby Stew-
art et al. (28). For total protein extraction, homogenateswere centrifuged
at 2500  g for 15 min at 4 C. For crude membrane fractions, the
resulting supernatants from the initial purification were centrifuged at
200,000 g for a further 30min at 4C. The supernatantswere decanted
and the resulting pellets containing crude membrane proteins resus-
pended in homogenization buffer. A Bio-Rad Protein Assay was used to
determine the concentration of solubilized protein (Bio-Rad Laborato-
ries, Inc., Hercules, CA).
Immunoblotting
Five-fold concentratedLaemmlibuffer solution [0.32MTris (pH6.8),
5% (wt/vol) sodium dodecyl sulfate, 25% (vol/vol) glycerol, and 1%
(wt/vol) bromophenol blue] was added to the protein samples in a 1:4
ratio in the presence and absence of the sulfhydryl (SH) group reducing
agent-mercaptoethanol (10%).Protein sampleswereheatedat95C for
10 min, and 5 g/lane (CS) or 25 g/lane (CNSS) of protein was frac-
tionated on 6% (CaSR) or 15% (STC-1) sodium dodecyl sulfate poly-
acrylamide gels. Electrophoresis and immunoblottingwere performed as
previously described (29). Immunoblots were probed with anti-CaSR
mouse monoclonal antibody (diluted 1–5,000), raised against amino
acids 214–235 of the human CaSR (Affinity BioReagents, Inc., Golden,
CO), or with antifish STC-1 (1–10,000) rabbit antiserum (from G.F.)
(30). Immunoblots for STC-1 were stripped and reprobed with anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1–1000) rabbit
antibody (Abcam, Cambridge, UK) to assess protein loading. Negative
controls were performed by omission of the primary antibody. Protein
deglycosylation was performed on 5 g CS protein in the absence and
presence of Peptide: N-Glycosidase F (PNGase F) following manufac-
turer’s guidelines (New England BioLabs, Ipswich, MA).
Animal experiments
Long-term acclimation to SW and FW
To determine the steady-state conditions of fully acclimated animals,
fish were studied after being held in SW or FW for 2 wk in October. Fish
were removed fromtanks andwithout anesthetic blood samples (3–6ml)
were collected within 90 sec into ammonium-heparinized syringes by
needle puncture of the caudal blood vessels. Blood was aliquoted into
ammonium-heparinized tubes and plasma separated by centrifugation
for 5 min at 13,000 g. The flounder were humanely killed, and tissues
were removed and immediately snap frozen in liquid nitrogen.
Experimental induction of acute hypocalcemia
A total of 56 flounder was acclimated to FW for 2 wk in September
before the induction of hypocalcemia by administration of a calcium-
chelating agent. Fish were split into four experimental groups related to
sampling time after treatment: 0.5, 1, 2, and 4 h. Fish were injected ip
with a single dose of either 150 mmol/liter NaCl (control vehicle) or 30
mol/100 g bodyweight EGTA in a volumeof 0.1ml/100 g bodyweight.
At each time point, treated fish (n  7) were sampled alongside time-
matched vehicle-injected controls (n 7). Blood samples (3–6 ml) were
collected as described previously, and plasma was separated by centrif-
ugation before analysis.
Effect of calcimimetics on plasma and urine composition
Flounder were acclimated to FW in May, and to achieve continuous
administration of reagents and permit serial blood sampling, fish were
implanted with an arterial cannula as previously described (31). After
48 h post-operation recovery, experimental animals were administered
1 mg/kg body weight of the calcimimetic agent R-568 via the implanted
cannula, and controls given the enantiomer S-568 (Amgen Inc., South
San Francisco, CA) in 200 l 150 mmol/liter saline (n  8 for each
group). Serial blood samples (200 l) were collected via the arterial
cannula 0, 0.5, 1, 2, 4, and 8 h after injection. Plasma was separated by
centrifugation, and red blood cells were resuspended in 150 mmol/liter
saline (200l) and placed back into the fish through the cannula. At 8 h,
animalswere killed and urine samples collected directly from the bladder
by needle puncture.
Plasma analysis
Osmolality was measured by freezing-point depression (Roebling
Micro-Osmometer; Camlab,Cambridge, UK), sodium, potassium,mag-
nesium, and total calcium concentrations were determined by atomic
absorption spectrophotometry (Solaar; Thermo Elemental, Winsford
Cheshire, UK), chloride concentrations were analyzed by electrode ti-
tration (Corning Chloride Analyzer 925; Corning, Inc., Corning, NY),
and phosphate concentrations were determined using an autoanalyzer
following the manufacturer’s protocols (SANPlus Segmented Flow An-
alyzer; Skalar Analytical B.V., Breda, The Netherlands). The ionized
calcium measures were determined using a Rapid 865 Blood Gas Ana-
lyzer (Bayer HealthCare, Leverkusen, Germany). Plasma STC-1 levels
were determined in duplicate on 100-l aliquots of plasma by RIA (17).
Statistical analysis
Statistical differences between experimental groups were evaluated
using independent sample t tests. P  0.05 was considered significant.
Results are expressed as mean  SE.
Results
The CaSR from flounder CS comprised a full-length cDNA of
3302 bp with an open-reading frame of 2802 bp encoding a
934-amino acid protein (Fig. 1A). The predicted amino acid se-
quence shared highest sequence identity to sea bream (94%),
tilapia (93%), and Fugu (91%)CaSRs, and lower sequence iden-
tity with the human (76%) and dogfish (75%) CaSRs (Fig. 1B).
The flounder CaSR contained characteristic features consis-
tent with members of family 3 of the GPCRs, with a large ex-
tracellular domain of 596 amino acids, a 246-amino acid mem-
brane spanning domain, and a small 92-amino acid C-terminal
intracellular domain (Fig. 1A). The large extracellular domain
included an 18-amino acid signal peptide, 11 potential sites for
N-linked glycosylation, 18 conserved cysteines, a hydrophobic
region, and a large number of conserved acidic residues. Acidic
residues in the second and third extracellular loops of the trans-
membrane domain are recognized in mammalian CaSRs to be
important in modulating the actions of calcium, gadolinium,
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allosteric modulators such as R-568, and organic polycations
(32,33). Fiveof the sixacidic residues in extracellular loops2and
3 were found at corresponding positions in the flounder CaSR,
suggesting that these residues may play important roles in the
regulationof receptor activation.The intracellular domainof the
flounder CaSR contained a number of consensus phosphoryla-
tion sites and amino acids involved in receptor trafficking.
Tissue mRNA distribution
Real-time quantitative PCR
The sensitive technique of quantitative PCR was used to deter-
mine CaSR and STC-1mRNA expression levels in a wide range of
SW tissues. Expression of CaSR mRNAs was not restricted to the
CS,withmoderate copynumbersdetected in theCNSS, testis, blad-
der, kidney, and gill, and detectable levels in all other tissues ana-
lyzed (Fig.2Ai).TheSTC-1copynumberwas
considerably higher in the CS by comparison
with other tissues (Fig. 2Bi). However, in this
case a secondmajor site of STC-1mRNAex-
pression was also identified, with the CNSS
expressing significantly higher copies of
STC-1 by comparison with all other tissues
analyzed with the exception of the CS.
Northern blotting
CaSR mRNA transcripts were only de-
tectable by Northern blot in the CS, where
twomain transcripts of approximately 3 and
4.5 kb were identified in 10 g total RNA
(Fig. 2Aii). Thebroadbandof approximately
3 kb is consistent with the predicted major
band size based on the full-length cDNA of
theflounderCaSR.Theidentityof theweaker
band of approximately 4.5 kb that was ob-
served is unknown but may represent an al-
ternatively spliced form of the flounder
CaSR.Thehigh levelofCaSRmRNAexpres-
sion in the CS corresponded with high levels
of STC-1, asdemonstratedbyNorthernanal-
ysis (Fig. 2Bii). Bands of approximately 2 kb,
closely matching the size of full-length floun-
der STC-1, and 3 kb were detected.
Characterization of the flounder CaSR
The CaSR monoclonal antibody recog-
nized a single broadband inCS immunoblots
under denaturing conditions,with lowermo-
lecular mass bands evident after addition of
the reducing agent -mercaptoethanol (Fig.
3A). Therewas a reduction in the intensity of
the broad band of 215–300 kDa, with the
appearanceofanadditional intense immuno-
reactive bandmigrating at a lowermolecular
mass of 120–150 kDa after the addition of
-mercaptoethanol.WhenCSproteinwas in-
cubated in the absence and presence of PN-
Gase F enzyme, the resulting immunoblots
showed that the original 215–300 and 120–150 kDa bands were
bothreducedbydeglycosylationto lowermolecularmassesof200–
240 and 90–120 kDa, respectively (Fig. 3B). Further immunoblot
analysis showed that the CaSR was predominantly located in the
membrane-enriched fraction rather than the supernatant contain-
ing cytosolic proteins (Fig. 3C). In the CNSS, CaSR-specific bands
of approximately 300, 140, and 104 kDa were also detected in
crude membrane (25 g) proteins (Fig. 3D). In contrast to the CS,
the intensity of the unglycosylated CaSR monomeric form (104
kDa) represented the greatest CaSR signal in the CNSS.
Animal experiments
Long-term acclimation to SW and FW
The impact of environmental salinity on ion regulatory sys-
tems was confirmed by analysis of plasma ion composition.
FIG. 1. Deduced amino acid sequence of flounder CaSR and homology tree for vertebrate CaSR sequences. A,
Deduced amino acid sequence of flounder CaSR. The location of the signal peptide (bold print), potential N-
linked glycosylation sites (underlined italics print), conserved cysteine residues (*), serine residues implicated in
receptor activation (underlined bold print), and a 24-amino acid hydrophobic segment (boxed) are indicated. The
transmembrane helices of the predicted seven transmembrane domain are shaded. Potential sites of protein
kinase C (	) and protein kinase A () phosphorylation are indicated below the sequence. The hash symbols in
the intracellular domain indicate amino acids (H and F) implicated in trafficking of the receptor to the cell
membrane (38). Amino acids shown to be involved in the binding of allosteric modulators R-568 and NPS 2143
in mammalian CaSRs are shown in bold print. B, Homology tree of selected fish and mammalian CaSR genes.
The Fugu pheromone receptor (FuPheR) has been used as the out-group sequence for this analysis. The
sequence alignment and identity analysis were performed using DNAMAN software using distance matrix and
Neighbor Joining methods. Dog, NP_001074978; human, NP_000379; bovine, NP_776427; mouse,
NP_038831; rat, NP_058692; flounder, ACN62418; sea bream, CAC41352; tilapia, AAT06805; Fugu,
BAA26122; salmon, NP_001119703.1; dogfish, AAM77700; FuguPheR, BAA26126.
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Plasma sodium (SW, 154.52
 1.76; FW, 141.80
 2.92), chlo-
ride (SW, 144.36
 1.39; FW, 121.50
 2.60), magnesium (SW,
2.80
 0.14; FW, 0.46
 0.02) concentrations (mmol/liter), and
osmolality (SW, 311 
 4; FW, 278 
 5 mosmol/liter) were sig-
nificantly higher (P 0.05) in SW vs. FW-adapted fish, whereas
plasma potassium, phosphate, total, and ionized calcium con-
centrations remained unchanged (data not shown).
This long-term acclimation of flounder to SW or FW did not
affect CaSR mRNA expression in the CS or CNSS (Fig. 4A).
Although there were no salinity related differences in CaSR
mRNA expression, STC-1 mRNA expression levels were signif-
icantly lower in both the CS and CNSS (Fig. 4A) of FW vs.
SW-adapted flounder. Notably, STC-1mRNA expression in the
CNSSofFWfishwas approximately 4-fold lowerby comparison
to SW-adapted flounder, consistent with a potential role for
STC-1 secretion from this neuroendocrine tissue in themarkedly
different ion regulatory demands of SW and FW fish. To deter-
mine the effect of salinity on CaSR and STC-1 protein expres-
sion, CS protein samples from SWand FW fishwere analyzed by
immunoblotting under reducing conditions (Fig. 4B). In FWCS,
the intensityof theCaSR-specific215–300kDacomplexwasmark-
edly reduced in intensity in comparison to SW CS glands. Fur-
thermore, the 120–150 kDa complex evident in SW CS glands
appeared as a 115–145 kDa complex in FW CS glands. Four
differentmolecularmass formsof STC-1between22and29kDa
were identified in CS extracts from SW fish. In contrast, only
threemolecularmass formswere identified inCSprotein samples
from FW fish. The highest molecular mass band was absent in
FWCS extracts, whereas densitometry confirmed a reduction in
the intensity of the two lower molecular mass bands in compar-
ison to SW samples (data not shown). Reprobing the STC-1 blot
with the loading control GAPDH showed that the higher ex-
pression levels in SW fish were not due to errors in protein load-
FIG. 2. Tissue distribution of CaSR (Ai) and STC-1 (Bi) mRNA. Results of real-time
quantitative PCR analysis of tissues from six SW-acclimated adult flounder. Values
are mean mRNA copies in 1 g total RNA calculated from a calibration curve
produced from known concentrations of recombinant plasmid DNA. A, CS 
CNSS  testis  bladder  kidney  gill  brain  ovary  spleen  head
kidney  mid (M)-gut  heart  skin  hind (H)-gut  bone  stomach  fore
(F)-gut  liver. B, CS  CNSS  brain  bladder  testis  ovary  kidney 
head kidney  spleen  bone  stomach  fore-gut  hind-gut  gill  skin.
STC-1 mRNA was not detectable in mid-gut, heart, and liver after 40
amplification cycles. Aii, and Bii, Northern blots illustrating the mRNA transcript
size of CaSR and STC-1 in total RNA samples (10 g) from the CS of three
(pooled RNA samples) SW-acclimated flounder. Blots were exposed to film at
80 C for 2 (STC-1) and 48 h (CaSR). The approximate size of each band on
each blot is indicated in kilobases (kb).
FIG. 3. Immunoblots of CaSR immunoreactivity in CS protein samples and
tissues of SW-adapted flounder using a CaSR-specific mouse monoclonal
antibody. A, Immunoblot of CS total protein (5 g/lane) in the absence () and
presence () of the SH-reducing agent -mercaptoethanol demonstrating that
almost all CaSR immunoreactivity migrates as a broad band of 215–300 kDa in
the absence of -mercaptoethanol. The addition of -mercaptoethanol to the
Laemmli buffer during denaturation resulted in a reduction of the intensity of the
215–300 kDa band together with the appearance of lower molecular mass
(120–150 and 104 kDa) immunoreactive bands. B, Deglycosylation of CaSR
protein. Immunoblot of CS total protein (5 g/lane), treated at 37 C for 1 h with
() or without () PNGase F, probed with CaSR antibody. The control signals
were reduced to lower molecular masses by deglycosylation. C, Immunoblot of
CS proteins (5 g/lane) after serial centrifugation. Each lane contains different
subcellular fractions: 200,000  g, crude membrane proteins; supernatant,
cytosolic proteins. The CaSR signals were strongest in the 200,000  g fractions
and virtually absent in the cytosolic protein fraction. D, CaSR-specific
immunoreactive bands were also identified in CNSS crude membrane protein
fractions (25 g/lane) at approximately 300, 140, and 104 kDa. No positive
staining was observed after the omission of the primary antibody. Molecular
mass marker (kDa).
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ing. The differences in STC-1 mRNA and protein levels in SW
and FWCS did not translate into changes in circulating levels of
immunoreactive STC-1 (Fig. 4C).
Experimental EGTA induction of acute hypocalcemia
To establish a link between circulating levels of ionized calcium
and plasma STC-1, fishwere injectedwith EGTA. The bolus injec-
tionof 30mole/100 gbodyweight of EGTAsignificantly reduced
circulating levels of ionized calcium in groups sampled at 0.5, 1, 2,
and 4 h, by comparison with the respective time-matched control
groups (Fig. 5A), inwhich ionized calciummeasures remained sim-
ilar for all time points. These lower ionized calciummeasures were
associatedwith reduced plasma levels of immunoreactive STC-1 in
the 1, 2, and 4-h sample groups compared with paired time-
matchedcontrols (Fig.5B).Allotherplasmaionmeasures remained
similar to controls during the experimental period.
The effect of calcimimetics on plasma and urine composition
At time zero, ionized and total plasma calcium concentrations
were similar between the two groups. The injection of R-568 sig-
nificantly lowered total calcium at 0.5, 1, and 2 h (Fig. 6A), and
ionized calcium levels at 1 and 2 h (Fig. 6B) when compared with
time-matched S-568-treated control fish. At 4 and 8 h after R-568
injection, there was some recovery in total calcium concentration
toward time zero levels.At time zero, plasmaphosphate levelswere
similar between the two groups. The injection of R-568 resulted in
the rapid onset of hypophosphatemia (Fig. 6C). Accordingly,
plasma phosphate levels were significantly lower after 30 min and
1 h in R-568 compared with S-568-treated fish. Furthermore, ad-
ministration of R-568 induced a steady decline in plasma magne-
sium levels (Fig. 6D). Plasmamagnesium concentrations were sim-
ilar at time zero between the two groups but were significantly
reduced at the 0.5, 1, 2, 4, and 8-h sampling points. The early onset
of hypocalcemia and hypophosphatemia after R-568 administra-
tion corresponded to significantly elevated levels of plasma immu-
noreactive STC-1 at 30 min compared with S-568-treated animals
(Fig. 6E). Plasma STC-1 levels were similar in R-568 and S-568
treatment groups 8 h after administration (Fig. 6E), when both
plasma calcium and phosphatemeasures were also similar to time-
matched controls. No differences in plasma concentrations of so-
dium, chloride, and potassium ions or osmolality were observed
over the experimental period.
The reduced plasma levels of both freely ionized and total
calcium were associated with significantly higher calcium levels
FIG. 4. Analysis of CaSR and STC-1 expression in CS and CNSS and plasma
immunoreactive STC-1 of flounder long term adapted to SW or FW. A, Tissue
expression levels were analyzed by real-time quantitative PCR with -actin as the
reference gene. There was no significant difference in CS or CNSS CaSR relative
mRNA expression when comparing SW and FW fish. In FW fish, STC-1 relative mRNA
expression was found to be significantly lower in CS and CNSS compared with SW
fish. B, CS total protein samples (5 g/lane) from SW and FW fish (n 3) were
denatured in Laemmli buffer in the presence of the reducing agent -
mercaptoethanol. Immunoblots were probed with either anti-CaSR mouse
monoclonal antibody or anti-STC-1 polyclonal antiserum. For STC-1 immunoblots,
protein loading was assessed by stripping and reprobing the membrane with anti-
GAPDH polyclonal antibody. C, Plasma STC-1 immunoreactivity in SW and FW
flounder plasma samples was measured by RIA. Independent sample t tests have
been used to assess differences between SW and FW flounder. Asterisks indicate
significant difference (*, P 0.05). Values are means SE of eight to 10 fish.
FIG. 5. The effects of single bolus ip injection of EGTA on plasma-ionized calcium
and immunoreactive STC-1 in FW flounder. A, EGTA administration significantly
lowered plasma-ionized calcium at all time points by comparison with paired time-
matched saline controls. B, Plasma immunoreactive STC-1 levels were significantly
reduced 1, 2, and 4 h (hr) after EGTA injection by comparison with paired time-
matched saline controls. Results are means SE (n 6–7 for each group). Asterisks
represent significant difference from paired time-matched controls (*, P 0.05;
**, P 0.01; ***, P 0.001) by independent sample t tests.
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in the urine of R-568 compared with S-568-treated fish 8 h after
injection (Fig. 6F). Similarly, urinemagnesium levels were found
to be 4-fold higher (Fig. 6H), whereas urine phosphate levels
were 50% lower in R-568 urine samples compared with S-568
urinemeasures (Fig. 6G). Sodium and potassium urinemeasures
and osmolality were similar between the treatment groups.
Discussion
To our knowledge this is the first study in which the regulation of
CaSR expression has been investigated in the CS. The flounder
CaSR possessed several structural features that assisted in the as-
signment of this molecule as a typical CaSR. Notably, cysteines
corresponding to Cys129 and Cys131 in the extracellular domain
of the human CaSR are critical for receptor dimerization (34, 35).
A similar orientation of these cysteines has been confirmed in the
tilapia CaSR (23), suggesting that, like the human receptor, teleost
CaSRsmay function as disulfide-linked dimers (29).Moreover, 11
potentialN-linkedglycosylation sites in the extracellulardomainof
the flounder CaSR were found to exist at the same positions cor-
responding to those in mammalian CaSRs (1, 24). Therefore, the
posttranslational processing of the flounder CaSRmay be similar
to mammalian CaSRs, with the variable addition of sugars
possibly resulting in a series of different molecular mass forms
(36).
Thedifferences inmolecularmassof theCaSRdependingon the
protein denaturation conditions reported here have been described
previously in mammals (29). On SDS-PAGE under nonreducing
conditions, the flounder CaSR exists in several forms with molec-
ular masses greater than 215 kDa. The higher molecular mass
forms likely represent dimeric species being greater than twice
the predicted molecular mass of the flounder CaSRmonomer.
Addition of the SH-reducing agent -mercaptoethanol dimin-
ished the intensity of the 215–300 kDa band with a concom-
itant appearance of CaSR reactive bands between 120 and 150
kDa, similar to those previously described in membrane pro-
teins prepared from the bovine parathyroid glands under de-
naturing and reducing conditions (36). The 215–300 and
120–150 kDa bands for flounder were shown to be sensitive
to PNGase F, similar to findings in mammals (37,38).Together,
these observations confirm that the CS CaSR exists as a disulfide-
linked dimer in the cellmembranes ofCS cellswith varying degrees
of glycosylation.
The flounder CaSR mRNAwas only detectable by Northern
blots of total RNA from the CS among the various flounder
tissues sampled. In mammalian Northern blots, CaSR mRNAs
have been found to be most abundant in parathyroid cells (1).
This very high level of CaSR expression in flounder CS is con-
sistent with the proposed function of the CaSR in regulating
STC-1 secretion (21).Although this is not the first reportofCaSR
expression in flounder CNSS, because we (39) previously iden-
tified CaSR immunoreactivity in the perikarya of Dahlgren cells
and axons of the spinal cord, the high expression of the CaSR
mRNA in the CNSS described in the current study was shown to
correspond with high levels of STC-1 mRNA expression as for
the CS. Thus, these observations lead to the notion that calcium
regulation could also bemodulated through the release of STC-1
from the CNSS in addition to the CS, perhaps providing a rapid
reacting component through this neuroendocrine tissue. In sup-
port of this, previous unpublishedwork fromour laboratory has
shown that plasma total calcium levels were elevated (2.69 

0.24 vs. 1.96
 0.25 mmol/liter) 24/48 h after CNSS removal in
flounder by comparison with sham-operated fish (n  4).
The lower STC-1 mRNA expression in CS and CNSS from
fish adapted to FW by comparison with SW provides further
evidence of the effects of environmental salinity on CS STC-1
synthesis (22, 25). The difference in STC-1 mRNA expression
between SWand FW fish occurred independently of any changes
in CaSR mRNA expression or circulating levels of ionized cal-
cium. This raises the possibility that changes in STC-1 mRNA
expression and protein synthesis in fish exposed to different sa-
linities may result from altered CaSR functional activity. Sup-
porting this theory is the diminished expression of putative
dimeric CaSR protein forms, together with altered levels of gly-
FIG. 6. The effect of a single arterial injection of 1 mg/kg R-568 (clear bars) or S-
568 (filled bars) on plasma total calcium (A), ionized calcium (B), phosphate (C), total
magnesium (D), STC-1 (E), and urine composition (F–H) in FW flounder. The data
(A–D) are shown as changes () in plasma ion concentration from time zero
measures for serial samples collected at 0.5, 1, 2, 4, and 8 h (hr) after R-568 or S-568
administration. E, Plasma STC-1 levels for two separate groups of fish terminally
sampled 0.5 and 8 h after R-568 or S-568 administration. F–H, Urine composition for
flounders sampled 8 h after calcimimetic administration. S-568-administered fish
have been used as controls for these analyses. Significant differences by comparison
with S-568-treated flounder in time-matched samples were assessed by independent
sample t tests (*, P 0.05; **, P 0.01; ***, P 0.001). Values are means SE
(n 8 fish per group).
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cosylation of the receptor monomer in FW compared with SW
fish CS. These differences potentially occur from changes in
plasma ionic strength between SW and FW fish because ionic
strength alters the sensitivity of both fish andmammalianCaSRs
whenexpressed inhumanembryonickidney cells (4, 40).Despite
detecting differences in mRNA expression and the molecular
mass protein forms of STC-1 in CS samples of SW and FW fish,
circulating levels of immunoreactive STC-1 were similar. There-
fore, plasma STC-1 levels do not reflect the apparent higher rates
of hormone synthesis and secretion of STC-1 fromCS of SW fish
in the present study. It has been shown that the metabolic clear-
ance rate of STC-1 is significantly higher in SW by comparison
with FW fish, indicatingmore target tissue and/or increased deg-
radation of STC-1 in clearance organs (41), which may explain
why plasma STC-1 levels were not higher in SW-adapted floun-
der. On the other hand, EGTA-induced hypocalcemia rapidly
lowered circulating levels of STC-1, providing a strong link be-
tween circulating levels of ionized calcium and STC-1 secretion.
In support of this view, EGTA has also been successfully used to
induce hypocalcemia in mammals, resulting, in this case, in in-
creased synthesis and secretion of PTH (42). The present study
complements previous converse in vivo investigations in which in-
creasing plasma calcium through calcium chloride administration
resulted in increased circulating levels of STC-1 (17). Therefore,
acute alterations in circulating levels of ionized calcium initiate ap-
propriatemodifications in circulating levels of STC-1, similar to the
relationship between PTH and ionized calcium in mammals (43).
As predicted from the CaSR structure, calcimimetics were
effective in flounder. There have been no previous reports of
calcimimetic actions on either plasma or urine composition in
fish, though R-467 administration has stimulated STC-1 secre-
tion and reduced gill calcium uptake in rainbow trout (21). The
calcimimetic, R-568, has consistently reduced PTH secretion
from parathyroid cells, leading to reduced plasma levels of total
and ionized calcium, phosphate and magnesium in mammals
(19, 20, 44, 45). Here, we report similar responses to R-568
administration in the flounder, with a comparable rate of onset
and level of hypocalcemia, hypophosphatemia, and hypomag-
nesia. The increased calciumandmagnesiumcontent of the urine
in R-568-treated fish suggest that the changes in plasma com-
position occur, at least in part, through increased renal excretion
of these ions. Similar to these effects of R-568 on phosphate
excretion in flounder, studies in rats also reported lower levels of
phosphate excretion resulting from calcimimetic administration
(45). Lu et al. (12) have already shown that salmon STC-1 has a
dose-dependent stimulatory effect on phosphate reabsorption in
flounder proximal tubule primary cultures. One possible expla-
nation for these coordinated effects is that STC-1 is promoting
phosphate reabsorption to chelate the excess calcium in the ex-
tracellular fluid compartment, which subsequently may lead to
increased deposition of calcium and phosphate in bone and
scales. Thus, it is likely that all of the reported responses toR-568
administration potentially result from calcimimetic-induced in-
creases in plasma STC-1 levels, evident here already 30min after
injection. This accords with the CS being a major site of CaSR
expression in fish and, therefore, the primary site of calcimimetic
actions.
In summary, it has been demonstrated that theCaSR is highly
expressed in fish CS cells comparable with mammalian para-
thyroid gland cells, consistent with the evidence presented for
calcium-stimulated STC-1 release in fish. The experimental se-
ries reported here provide evidence of associations between en-
vironmental salinity,CaSR, and STC-1 expression in theCS, and
strongly support a role for ionized calcium in the regulation of
STC-1 secretion. The reported effects of the calcimimetic are
likely mediated predominantly by increased secretion of STC-1
from the CS via CaSR activation, as is the case for PTH and CT
secretion in mammals. Therefore, the CaSR represents a key
consistent component of themajor calciumregulatory systems in
fish andmammals in that theyboth appear tobe regulated via the
CaSR, albeit hypocalcemic (STC-1) mechanisms dominate in
fish, whereas hypercalcemic (PTH) systems predominate in
mammals.
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